Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.

Mooren JJ, Gültekin SE, Straetmans JM, Haesevoets A, Peutz-Kootstra CJ, Huebbers CU, Dienes HP, Wieland U, Ramaekers FC, Kremer B, Speel EJ, Klussmann JP.

Int J Cancer. 2014 May 1;134(9):2108-17. doi: 10.1002/ijc.28534. Epub 2013 Oct 21.

2.

A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.

Deng Z, Hasegawa M, Aoki K, Matayoshi S, Kiyuna A, Yamashita Y, Uehara T, Agena S, Maeda H, Xie M, Suzuki M.

Int J Oncol. 2014 Jul;45(1):67-76. doi: 10.3892/ijo.2014.2440. Epub 2014 May 12.

3.

Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.

Young RJ, Urban D, Angel C, Corry J, Lyons B, Vallance N, Kleid S, Iseli TA, Solomon B, Rischin D.

Br J Cancer. 2015 Mar 17;112(6):1098-104. doi: 10.1038/bjc.2015.59.

4.

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.

Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K.

Cancer Med. 2013 Dec;2(6):933-41. doi: 10.1002/cam4.151. Epub 2013 Oct 27.

5.

HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?

Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, Görögh T, Halec G, Hoffmann AS, Kahn T, Röcken C, Haag J, Waterboer T, Schmitt M.

Cancer Lett. 2012 Oct 1;323(1):88-96. doi: 10.1016/j.canlet.2012.03.033. Epub 2012 Apr 3.

PMID:
22484467
6.

Combined P16 and human papillomavirus testing predicts head and neck cancer survival.

Salazar CR, Anayannis N, Smith RV, Wang Y, Haigentz M Jr, Garg M, Schiff BA, Kawachi N, Elman J, Belbin TJ, Prystowsky MB, Burk RD, Schlecht NF.

Int J Cancer. 2014 Nov 15;135(10):2404-12. doi: 10.1002/ijc.28876. Epub 2014 Apr 17.

7.

The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.

Doxtader EE, Katzenstein AL.

Hum Pathol. 2012 Mar;43(3):327-32. doi: 10.1016/j.humpath.2011.05.010. Epub 2011 Aug 12.

PMID:
21840041
8.

Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.

Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y.

Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17.

PMID:
26997438
9.

HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.

Wang H, Zhang Z, Sun R, Lin H, Gong L, Fang M, Hu WH.

J Voice. 2015 May;29(3):356-62. doi: 10.1016/j.jvoice.2014.08.016. Epub 2014 Dec 4.

PMID:
25484261
10.

P16(INK 4a) and Ki-67 expression in human papilloma virus-related head and neck mucosal lesions.

Gültekin SE, Sengüven B, Klussmann JP, Dienes HP.

Invest Clin. 2015 Mar;56(1):47-59.

PMID:
25920185
11.

Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?

Thomas J, Primeaux T.

Ann Diagn Pathol. 2012 Apr;16(2):91-9. doi: 10.1016/j.anndiagpath.2011.09.002. Epub 2011 Dec 23.

PMID:
22197546
12.

Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.

Evans MF, Matthews A, Kandil D, Adamson CS, Trotman WE, Cooper K.

Head Neck Pathol. 2011 Dec;5(4):344-8. doi: 10.1007/s12105-011-0282-y. Epub 2011 Jul 24.

13.

High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions.

Laco J, Slaninka I, Jirásek M, Celakovský P, Vosmiková H, Ryska A.

Pathol Res Pract. 2008;204(8):545-52. doi: 10.1016/j.prp.2008.03.001. Epub 2008 Apr 28.

PMID:
18440161
14.

HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?

Orsaria M, Marzinotto S, De Marchi L, Giacomarra V, Boria S, Rubini C, Londero AP, Di Loreto C, Mariuzzi L.

Anticancer Res. 2015 Sep;35(9):4733-9.

PMID:
26254363
15.

Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.

Chernock RD, Wang X, Gao G, Lewis JS Jr, Zhang Q, Thorstad WL, El-Mofty SK.

Mod Pathol. 2013 Feb;26(2):223-31. doi: 10.1038/modpathol.2012.159. Epub 2012 Sep 21.

16.

Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.

Holzinger D, Schmitt M, Dyckhoff G, Benner A, Pawlita M, Bosch FX.

Cancer Res. 2012 Oct 1;72(19):4993-5003. doi: 10.1158/0008-5472.CAN-11-3934. Epub 2012 Sep 18.

17.

Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes.

Quon H, Cohen MA, Montone KT, Ziober AF, Wang LP, Weinstein GS, O'Malley BW Jr.

Laryngoscope. 2013 Mar;123(3):635-40. doi: 10.1002/lary.22172. Epub 2013 Feb 1.

PMID:
22588642
18.

Biomarkers of HPV in head and neck squamous cell carcinoma.

Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT.

Cancer Res. 2012 Oct 1;72(19):5004-13. doi: 10.1158/0008-5472.CAN-11-3277. Epub 2012 Sep 18.

19.

Human papillomavirus status in young patients with head and neck squamous cell carcinoma.

van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ.

Int J Cancer. 2012 Apr 15;130(8):1806-12. doi: 10.1002/ijc.26195. Epub 2011 Aug 2.

20.

Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.

Linxweiler M, Bochen F, Wemmert S, Lerner C, Hasenfus A, Bohle RM, Al-Kadah B, Takacs ZF, Smola S, Schick B.

Cancer Cytopathol. 2015 Apr;123(4):219-29. doi: 10.1002/cncy.21512. Epub 2014 Dec 29.

Items per page

Supplemental Content

Write to the Help Desk